INNOVATIVE EYEWEAR, INC. (LUCY) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $64.00; Additional Paid in CapitalUSD $43.21M; Retained Earnings (Accumulated Deficit)USD $-36.31M; Stockholders' Equity Attributable to ParentUSD $6.90M.
- 2026-03-31: Common Stock, Value, IssuedUSD $63.00; Additional Paid in CapitalUSD $43.01M; Retained Earnings (Accumulated Deficit)USD $-34.64M; Stockholders' Equity Attributable to ParentUSD $8.37M.
- 2025-12-31: Common Stock, Value, IssuedUSD $55.00; Additional Paid in CapitalUSD $41.39M; Retained Earnings (Accumulated Deficit)USD $-32.33M; Stockholders' Equity Attributable to ParentUSD $9.07M.
- 2025-09-30: Common Stock, Value, IssuedUSD $52.00; Additional Paid in CapitalUSD $40.71M; Retained Earnings (Accumulated Deficit)USD $-30.46M; Stockholders' Equity Attributable to ParentUSD $10.25M.
INNOVATIVE EYEWEAR, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64.00 | $43.21M | $-36.31M | $6.90M | 3 month · $198.32K | (m) |
| 2026-03-31 | $63.00 | $43.01M | $-34.64M | $8.37M | 3 month · $200.99K | (m) |
| 2025-12-31 | $55.00 | $41.39M | $-32.33M | $9.07M | 12 month · $710.25K | (m) |
| 2025-09-30 | $52.00 | $40.71M | $-30.46M | $10.25M | 3 month · $169.30K | (m) |
| 2025-06-30 | $48.00 | $39.90M | $-28.62M | $11.28M | 3 month · $164.71K | (m) |
| 2025-03-31 | $25.00 | $34.01M | $-26.51M | $7.49M | 3 month · $177.58K | (m) |
| 2024-12-31 | $25.00 | $33.83M | $-24.74M | $9.10M | 12 month · $676.62K | (m) |
| 2024-10-31 | (m) | (m) | (m) | (m) | (m) | 2 month · $400.00K |
| 2024-09-30 | $24.00 | $33.54M | $-22.61M | $10.93M | 3 month · $105.08K | (m) |
| 2024-06-30 | $15.00 | $28.23M | $-20.89M | $7.34M | 3 month · $173.31K | (m) |
| 2024-03-31 | $132.00 | $22.84M | $-18.94M | $3.90M | 3 month · $232.15K | (m) |
| 2023-12-31 | $7.00 | $22.53M | $-16.97M | $5.56M | 12 month · $936.77K | (m) |
| 2023-09-30 | $129.00 | $22.22M | $-14.58M | $7.64M | 3 month · $242.24K | (m) |
| 2023-06-30 | $129.00 | $21.98M | $-13.02M | $8.95M | 3 month · $-40.18K | (m) |
| 2023-03-31 | $77.00 | $16.29M | $-11.74M | $4.55M | 3 month · $424.43K | (m) |
| 2022-12-31 | $73.00 | $14.33M | $-10.31M | $4.02M | 12 month · $1.47M | (m) |
| 2022-09-30 | $73.00 | $14.00M | $-8.43M | $5.57M | 3 month · $305.24K | (m) |
| 2022-06-30 | $60.00 | $5.68M | $-7.02M | $-1.35M | 3 month · $416.95K | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-582.09K | 3 month · $416.95K | (m) |
| 2021-12-31 | $60.00 | $4.84M | $-4.62M | $207.52K | 12 month · $1.33M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $30.87K | 3 month · $495.77K | (m) |
| 2021-06-30 | (m) | (m) | (m) | $104.48K | 3 month · $160.93K | (m) |
| 2021-03-31 | (m) | (m) | (m) | $-460.60K | 3 month · $38.06K | (m) |
| 2020-12-31 | (m) | (m) | (m) | $-554.84K | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |